Immunization Against Tumor Cells in Sezary Syndrome
NCT00099593
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous T-cell Lymphoma
Sezary Syndrome
Interventions
BIOLOGICAL:
Autologous Dendritic Cell Vaccine
Sponsor
University of Pittsburgh